Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Ambu A/S

Healthcare US AMBFF

9.85USD
0.00(0%)

Last update at 2026-06-22T20:00:00Z

Day Range

9.909.90
LowHigh

52 Week Range

12.3418.30
LowHigh

Fundamentals

  • Previous Close 9.85
  • Market Cap3446.29M
  • Volume197
  • P/E Ratio40.63
  • Dividend Yield3.00%
  • EBITDA858.00M
  • Revenue TTM6085.00M
  • Revenue Per Share TTM22.86
  • Gross Profit TTM 3655.00M
  • Diluted EPS TTM0.32

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-12-31 2022-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-12-31 2022-09-30
Income before tax 753.56M 300.00M 210.00M 109.00M 109.00M
Minority interest - - - - -
Net income 607.84M 235.00M 168.00M 93.00M 93.00M
Selling general administrative - 660.00M 594.00M 517.00M 517.00M
Selling and marketing expenses - 1571.00M 1522.00M 1634.00M 1634.00M
Gross profit 3373.00M 3201.00M 2713.00M 2554.00M 2554.00M
Reconciled depreciation - 355.00M 348.00M 351.00M 351.00M
Ebit 783.71M 327.00M 296.00M 144.00M 191.00M
Ebitda 1155.00M 682.00M 644.00M 495.00M 492.00M
Depreciation and amortization 371.29M 355.00M 348.00M 351.00M 301.00M
Non operating income net other - - - - -
Operating income 782.51M 645.00M 302.00M -26.00000M -26.00000M
Other operating expenses 5243.00M 4746.00M 4473.00M 4322.00M 4322.00M
Interest expense 29.94M 27.00M 86.00M 32.00M 32.00M
Tax provision - 65.00M 42.00M 16.00M 16.00M
Interest income - 15.00M 1.00M 1.00M 1.00M
Net interest income - -12.00000M -60.00000M -31.00000M -31.00000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 145.72M 65.00M 42.00M 16.00M 16.00M
Total revenue 6026.00M 5391.00M 4775.00M 4444.00M 4444.00M
Total operating expenses 2590.00M 2556.00M 2411.00M 2432.00M 2432.00M
Cost of revenue 2653.00M 2190.00M 2062.00M 1890.00M 1890.00M
Total other income expense net -29.00000M -345.00000M -92.00000M 135.00M -13.00000M
Discontinued operations - - - - -
Net income from continuing ops - 235.00M 168.00M 93.00M 93.00M
Net income applicable to common shares - - - 93.00M 93.00M
Preferred stock and other adjustments - - - - -
Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-12-31 2022-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-12-31 2022-09-30
Total assets 7660.00M 7154.00M 6859.00M 7215.00M 7215.00M
Intangible assets 1749.00M 1703.00M 2046.00M 1942.00M 1942.00M
Earning assets - - - - -
Other current assets 111.37M 155.00M 178.00M 11.00M 148.00M
Total liab 1637.00M 1560.00M 1466.00M 2954.00M 2954.00M
Total stockholder equity 6024.00M 5594.00M 5393.00M 4261.00M 4261.00M
Deferred long term liab - - - - -
Other current liab 506.24M 445.00M 501.00M 482.00M 465.00M
Common stock 134.74M 135.00M 135.00M 129.00M 129.00M
Capital stock - 135.00M 135.00M 129.00M 129.00M
Retained earnings 5853.00M 5212.00M 5047.00M 3753.00M 3753.00M
Other liab - - - 27.00M 27.00M
Good will 1494.00M 1527.00M 1565.00M 1623.00M 1623.00M
Other assets - - - 70.00M 70.00M
Cash 864.35M 615.00M 157.00M 187.00M 187.00M
Cash and equivalents - - - - -
Total current liabilities 1157.00M 1059.00M 942.00M 1161.00M 1161.00M
Current deferred revenue - - - - -
Net debt -318.39300M -57.00000M 427.00M 1658.00M 1658.00M
Short term debt 79.85M 75.00M 72.00M 79.00M 79.00M
Short long term debt - - - - -
Short long term debt total 545.96M 558.00M 584.00M 1845.00M 1845.00M
Other stockholder equity - 247.00M 211.00M 379.00M 379.00M
Property plant equipment - - - 1276.00M 1276.00M
Total current assets 3151.00M 2637.00M 2008.00M 2304.00M 2304.00M
Long term investments - - - - -
Net tangible assets - - - 696.00M 696.00M
Short term investments - - - - -
Net receivables 905.27M 789.00M 810.00M 747.00M 783.00M
Long term debt - - 0.00000M 1250.00M 1250.00M
Inventory 1270.00M 1078.00M 907.00M 1222.00M 1222.00M
Accounts payable 570.91M 490.00M 359.00M 600.00M 600.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 35.93M 145.00M 211.00M - 379.00M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other -0.73900M - 85.00M - -4841.00000M
Deferred long term asset charges - - - - -
Non current assets total 4509.00M 4517.00M 4851.00M 4911.00M 4911.00M
Capital lease obligations - 558.00M 584.00M 595.00M 595.00M
Long term debt total - - - - -
Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-12-31 2022-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-12-31 2022-09-30
Investments - -289.00000M -326.00000M -558.00000M -558.00000M
Change to liabilities - - - 287.00M 287.00M
Total cashflows from investing activities -383.00000M -289.00000M -326.00000M -558.00000M -558.00000M
Net borrowings - 0.00000M -1250.00000M 648.00M 648.00M
Total cash from financing activities -153.00000M -65.00000M -222.00000M 586.00M 586.00M
Change to operating activities - - - - -
Net income 607.84M 235.00M 168.00M -26.00000M -26.00000M
Change in cash 280.14M 458.00M -30.00000M 123.00M 123.00M
Begin period cash flow 584.21M 157.00M 187.00M 64.00M 64.00M
End period cash flow 864.35M 615.00M 157.00M 187.00M 187.00M
Total cash from operating activities 789.50M 813.00M 518.00M 95.00M 95.00M
Issuance of capital stock - 0.00000M 1091.00M 12.00M 12.00M
Depreciation 371.29M 696.00M 348.00M 351.00M 351.00M
Other cashflows from investing activities - -88.00000M -255.00000M - 5.00M
Dividends paid 101.00M - - -75.00000M 75.00M
Change to inventory -252.00000M -170.00000M 237.00M -402.00000M -402.00000M
Change to account receivables -107.00000M -40.00000M -47.00000M -19.00000M -19.00000M
Sale purchase of stock - - - 773.00M 773.00M
Other cashflows from financing activities -62.97900M -65.00000M -63.00000M 1.00M 1.00M
Change to netincome - - - -155.00000M -155.00000M
Capital expenditures 117.00M 289.00M 326.00M 558.00M 558.00M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -281.00000M -114.00000M -21.00000M -134.00000M -134.00000M
Stock based compensation - 26.00M 17.00M 12.00M 12.00M
Other non cash items 91.36M -30.00000M 84.00M -108.00000M -108.00000M
Free cash flow 672.72M 524.00M 192.00M -463.00000M -463.00000M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AMBFF
Ambu A/S		 - -% 9.85 40.63 36.23 0.57 3.81 3.02 16.91
ABT
Abbott Laboratories		 2.70 3.07% 90.53 25.97 17.24 3.57 3.20 3.81 16.75
SYK
Stryker Corporation		 5.31 1.74% 310.00 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 1.36 1.72% 80.63 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 1.27 2.86% 45.60 31.49 17.24 4.41 3.65 4.88 19.19

Reports Covered

Stock Research & News

View All

Profile

Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products; and cardiology products comprising ECG electrodes. It also provides airway management and anaesthesia products, which include double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers emergency care and training products, such as extrication collars and ALS and BLS training manikins, as well as mobile workstations, IOMs, and patient monitoring and diagnostics devices. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.

Ambu A/S

Baltorpbakken 13, Ballerup, Denmark, 2750

Key Executives

Name Title Year Born
Ms. Britt Meelby Jensen Chief Exec. Officer 1973
Mr. Thomas Frederik Schmidt Exec. VP & CFO 1971
Mr. Thomas Lykke Henriksen Head of HR Systems 1973
Mr. Henrik Ankjær Exec. VP of Global Operations NA
Mr. Nicolai Thomsen Director of Investor Relations & Strategic Financial Planning NA
Mikkel Trier Wagner Director of Corp. Communications NA
Mr. Bassel Rifai Exec. VP, Chief Marketing Officer & Pres APAC NA
Mr. Anders F. Williamsson Managing Director 1954
Mr. Måns Barsne Exec. VP of Global Innovation & Chief Innovation Officer NA
Mr. Steven R. Block CEO & Pres of USA 1963

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.